NCT00120185View on ClinicalTrials.gov

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

PHASE2CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

HIV Infections

Interventions

DRUG

Interleukin-2

Trial Locations (1)

75010

Service des Maladies Infectieuses, Paris

Sponsors

Collaborators (1)

Chiron Corporation

All Listed Sponsors

collaborator

Chiron Corporation

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00120185 - Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119) | Biotech Hunter | Biotech Hunter